Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Product/Service, Award

GN MEDI Antibacterial Spray Launched to End COVID-19 Crisis and Solve the Shortage of Masks


Ventex launched GN MEDI 99.9% antibacterial spray which is an eco-friendly and odorless product containing harmless minerals for sterilization and disinfection.

The product is developed by Ventex, a technology company that received IR52 Jang Young-shil Awards hosted by MSIT five times. Ventex received the awards in 2019, thanks to the antibacterial spray that featured the world's first ?coating technique with antibacterial mineral'.

GN MEDI 99.9% antibacterial spray eliminates 99.9 percent of pneumococcus, colon bacillus, and staphylococcus aureus. And Korea Testing & Research Institute checked that it sterilized 99.99 percent of Influenza A virus that is the same RNA virus family as COVID-19.

Nationally Authorized Testing- Inspection and Research Institute, KOTITI checked that the masks' filters worked fine after spraying the antibacterial spray on KF94 masks. They checked filters' functions under criteria, passing the amount of paraffin oil per minute following the test method of KF masks. It was widely known that KF94 masks usually prevent ninety-four percent.

When KOTITI tested pneumococcus after seventy-two hours from spraying the antibacterial spray on the mask, the mask had maintained 99.9 percent of excellent antibacterial function. The spray also eliminates the offensive smell.

Gyeongchan Go, President of Ventex said, "GN MEDI 99.9% antibacterial spray maintains the antibacterial effect for a long time compared to highly volatile ethanol and has an excellent safety unlike chlorine-releasing products causing cancers. Now you can use our spray that passed the skin irritation test for clothing and textile products as well as doorknobs, hand straps on the metro, and elevator buttons."

The antibacterial spray is also used for sterilization, disinfection, and deodorization and acknowledged by KATRI that they fit for a stability standard of risk-concerned products. The safety test result will come out from U.S. Food and Drug Administration (FDA) during this month.


These press releases may also interest you

at 15:02
Prominently featured in The Inner Circle, Lee C. Ferguson, DO, FACS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Vascular Surgeon. Dr. Ferguson, a distinguished dual board-certified vascular surgeon and endovascular...

at 15:00
The Honourable David J. McGuinty, Member of Parliament for Ottawa South,  on behalf of the Honourable Mark Holland, Minister of Health, will hold a news conference to announce funding to improve palliative care. MP McGuinty will be available to...

at 14:43
Sugar Kayne Radio, an innovative internet radio station founded by Matthew Kayne, also known as DJ Sugar Kayne, is set to launch on 2nd June. Located in the heart of North West London, Sugar Kayne Radio aims to revolutionize the online music...

at 14:38
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars," by Sarah Yim,...

at 14:32
Curve Health, a trailblazer in innovative healthcare solutions, is proud to announce a strategic partnership with MindCare, a leading provider of behavioral health services, with a focus on enhancing care delivery within Skilled Nursing Facilities...

at 14:05
Yoneda Labs, the Y Combinator startup building a foundation model for chemists working in drug discovery, today announced it has raised $4 million in seed capital from Khosla Ventures, 500 Emerging Europe, 468 Capital, Fellows Fund, and Y Combinator....



News published on and distributed by: